Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Microplastics Found in Human Heart Tissues, Both Before and After Surgical Procedures
08/31/2023

American Chemical Society News

American Chemical Society News ...
Various microplastics can accumulate and persist in the heart and its innermost tissues. The findings show how invasive medical procedures are an overlooked route of microplastics exposure.
Various microplastics can accumulate and persist in the heart and its innermost tissues. The findings show how invasive medical procedures are an overlooked route of microplastics exposure.
Various microplastics can...
08/31/2023
Cath Lab Digest
News
High Mortality in Cardiogenic Shock Despite Extracorporeal Life Support (ECLS)
08/31/2023

Universität Leipzig News

Universität Leipzig News
In patients with acute myocardial infarction and subsequent cardiogenic shock, ECLS therapy plus intensive care unit optimal medical therapy was compared with optimal medical therapy at the intensive care unit alone.
In patients with acute myocardial infarction and subsequent cardiogenic shock, ECLS therapy plus intensive care unit optimal medical therapy was compared with optimal medical therapy at the intensive care unit alone.
In patients with acute...
08/31/2023
Cath Lab Digest

Advertisement

News
Study: Inequities in Cardiovascular Care Putting Older Females' Heart Health at Risk
08/30/2023
Higher stroke risk among females with atrial fibrillation may be related to sex-based disparities in cardiovascular care, according to a new study.
Higher stroke risk among females with atrial fibrillation may be related to sex-based disparities in cardiovascular care, according to a new study.
Higher stroke risk among females...
08/30/2023
Cath Lab Digest
News
New Drug (Muvalaplin, Eli Lilly) Offers Treatment for Lipoprotein(a), a Largely Genetic Form of Cholesterol That Increases Risk of Heart Attack/Stroke
08/30/2023

Monash University News

Monash University News
The trial demonstrated the success of Muvalaplin - the first oral drug ever developed to target Lp(a) - effectively lowering levels by up to 65%. It works by disrupting the ability for Lp(a) to form in the body.
The trial demonstrated the success of Muvalaplin - the first oral drug ever developed to target Lp(a) - effectively lowering levels by up to 65%. It works by disrupting the ability for Lp(a) to form in the body.
The trial demonstrated the...
08/30/2023
Cath Lab Digest
News
Parental Incarceration Increases Levels of Hypertension and Coronary Disease Biomarkers in Youth
08/30/2023

University of Chicago Medicine News

University of Chicago Medicine News ...
The researchers analyzed data from over 9,600 young adults between the ages of 33 and 44 in the National Longitudinal Study of Adolescent to Adult Health (Add Health) — a robust, nationally representative dataset.
The researchers analyzed data from over 9,600 young adults between the ages of 33 and 44 in the National Longitudinal Study of Adolescent to Adult Health (Add Health) — a robust, nationally representative dataset.
The researchers analyzed data...
08/30/2023
Cath Lab Digest

Advertisement

News
Study Shows Benefit of Routine Genetic Testing of Dilated Cardiomyopathy Patients With Advanced Heart Disease
08/30/2023

Ohio State University Wexner Medical Center News

Ohio State University Wexner Medical ...
Researchers found that DCM patients with advanced heart disease, defined as having a heart transplant or left ventricular assist device (LVAD), are nearly 2 ½ times more likely to have a mutation in a relevant DCM gene than those with less...
Researchers found that DCM patients with advanced heart disease, defined as having a heart transplant or left ventricular assist device (LVAD), are nearly 2 ½ times more likely to have a mutation in a relevant DCM gene than those with less...
Researchers found that DCM...
08/30/2023
Cath Lab Digest
News
ESC: Colchicine Fails to Reduce Primary Outcomes in COP-AF Trial But Encouraging Signals Found
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
The COP-AF trial evaluated whether colchicine reduced occurrence of perioperative AF and myocardial injury after patients underwent non-cardiac thoracic surgery.
The COP-AF trial evaluated whether colchicine reduced occurrence of perioperative AF and myocardial injury after patients underwent non-cardiac thoracic surgery.
The COP-AF trial evaluated...
08/29/2023
Cath Lab Digest
News
NOAH-AFNET 6 Trial: Oral Anticoagulation is Not Effective in Patients With Atrial High-Rate Episodes
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
NOAH-AFNET 6 was the first trial to investigate the efficacy and safety of oral anticoagulation in patients with atrial high rate episodes (AHRE), but without ECG-documented atrial fibrillation.
NOAH-AFNET 6 was the first trial to investigate the efficacy and safety of oral anticoagulation in patients with atrial high rate episodes (AHRE), but without ECG-documented atrial fibrillation.
NOAH-AFNET 6 was the first trial...
08/29/2023
Cath Lab Digest

Advertisement

News
MULTISTARS AMI Trial Investigates Timing of Complete Revascularization for Myocardial Infarction
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
The MULTISTARS AMI trial investigated whether immediate complete revascularization at the time of primary PCI was non-inferior to staged (within 19 to 45 days) multivessel PCI.
The MULTISTARS AMI trial investigated whether immediate complete revascularization at the time of primary PCI was non-inferior to staged (within 19 to 45 days) multivessel PCI.
The MULTISTARS AMI trial...
08/29/2023
Cath Lab Digest
News
OCTOBER Trial: OCT Improves Stent Implantation Outcomes in Bifurcation Lesions
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
OCTOBER was the first adequately powered clinical trial to examine whether routine use of OCT during PCI of complex bifurcation lesions improves clinical outcomes.
OCTOBER was the first adequately powered clinical trial to examine whether routine use of OCT during PCI of complex bifurcation lesions improves clinical outcomes.
OCTOBER was the first adequately...
08/29/2023
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use